Exploring the Role of Biomarkers in Lung Cancer Treatment
Project Oncology® - Een podcast door ReachMD
Categorieën:
Host: Jacob Sands, MD Guest: Biagio Ricciuti, MD Treatment for lung cancer can be complex, but PL-L1 expression and tumor mutational burden might help us select the best treatment for our patients. What do we need to know about the role of these biomarkers in the treatment of lung cancer? To discuss this, Dr. Jacob Sands is joined by Dr. Biagio Ricciuti, a medical oncologist at the Dana-Farber Cancer Institute.
